CHRNA4 and Cowden syndrome 1: Inhibition of nAChR by SARS-CoV-2 leads to inhibition of PSNS and exaggeration of SNS with subsequent progression of CS due to inhibition of vagal anti-inflammatory mediated by diminution of nAChR activity (33).